Ramat Gan, Israel · Founded 2023 · Privately Held (backing)
Developer of surgical planning and personalised implant software designed to enable on-site creation of patient-specific medical devices. CustoMED is based in Ramat Gan, Israel and was founded in 2023. Its last reported valuation was $7.1 million in Oct 2025. It has raised $6 million.
Last reported valuation
$7.1M
Oct 2026
Priced at
—
Total raised
$6.0M
Last round
—
No prints on record
No secondary trades in CustoMED shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Private Market View
More of CustoMED with a free Private Market View account
·Watch CustoMED: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of CustoMED stock.
